Skip to main content

Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments

Philips Alturion ultrasound system

Philips Alturion ultrasound system
Philips Alturion ultrasound system

July 8, 2026

Newest addition to the Philips ultrasound portfolio, Alturion recently received FDA 510(k) clearance and CE mark, expanding access to advanced imaging and workflow innovation across clinical settings

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Alturion ultrasound system with AI-powered workflow built for high-volume settings. Available in the USA and Europe following FDA 510(k) clearance and CE mark certification, Alturion helps clinicians work more efficiently, deliver consistent results, and make confident clinical decisions.

As healthcare providers manage growing demand and increasing operational complexity, ultrasound teams need solutions that help improve efficiency without compromising quality. With the introduction of Alturion, Philips expands its ultrasound portfolio by bringing together advanced imaging, AI-powered workflows and a connected ecosystem that is designed to help streamline examinations and support consistency across users and clinical settings.

“At Philips, our goal is to develop technology that adapts to the realities of modern healthcare and helps care teams work more effectively in increasingly demanding clinical environments,” said Jie Xue, Chief Business Leader, Precision Diagnosis at Philips. “Alturion was designed with that goal in mind, helping healthcare providers deliver high-quality care with greater efficiency and confidence.”

Performance and usability across care settings
Alturion’s powerful processing architecture supports responsive performance and clear visualization across patients and exam types. With an expansive 24-inch monitor and a small footprint, the system enables easy movement from department to bedside and supports space utilization. Streamlined, intuitive workflows help reduce manual adjustments and exam time, helping providers manage high patient volumes, while a familiar user interface supports operational simplicity and consistency across care teams. 

Alturion is the newest ultrasound system to include Elevate Plus with AI-powered measurements for abdominal ultrasound. AI-enabled capabilities help streamline acquisition, automate measurements, and support reproducibility. By helping reduce variability and save time, these tools can contribute to more consistent exams and support clinical decision-making.

A connected ultrasound ecosystem
Alturion fits within Philips’ connected ultrasound ecosystem, sharing a common user interface and interchangeable transducers that are compatible with EPIQ Elite and Affiniti systems. By enabling sonographers and clinicians to use the same transducers across multiple systems, healthcare organizations can help simplify training, accelerate onboarding and support consistent workflows across departments. Philips’ complete general imaging ultrasound portfolio is designed for upgradeability and is compatible with Collaboration Live, a tele-ultrasound capability that enables multiple users to connect in real time for remote support, training and consultation.

For more information on Alturion, please visit here.

For further information, please contact: 

Jayme Maniatis 
Philips Global External Relations  
Tel.: 617-894-8368 
E-mail: jayme.maniatis@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 64,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.